Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Abbott™ Biosite™ Triage™ Drugs of Abuse Panel

Immunoassay for the qualitative determination of the presence of parent compound and/or major metabolites of up to nine distinct drug classes in urine

Supplier:  Abbott™ 92000

 View more versions of this product

Catalog No. 23-034-973

Item Discontinued Due to product restrictions, please to purchase or view availability for this product.This item has been discontinued by the supplier.


Description

Description

  • Test results from a urine sample in about 10 minutes
  • CLIA Complexity: Moderate
  • A self-contained, disposable, credit card-sized test device
  • Easy-to-read results for up to nine drug classes
  • Tests include amphetamines/methamphetamines, barbiturates, benzodiazepines, cocaine, marijuana, methadone, opiates, PCP and tricyclic antidepressants
  • The presence of color in any drug detection zone indicates the presence of the drug at or above the threshold concentrations
  • Built-in positive and negative controls in every device validate results
  • Kit sizes available in 25 test configurations

Specifications

Specifications

Moderate
Triage™ Drugs of Abuse Panel plus TCA
25 Tests
Urine
Amphetamines, Methamphetamines, Barbiturates, Benzodiazepines, Cocaine, Marijuana, Methadone, Opiates, PCP, Propoxyphene and Tricyclic Antidepressants
10 min.
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit